Регистр резистентной артериальной гипертонии –РЕзистентная Гипертония АрТериАльная (РЕГАТА):программа исследования
Регистр резистентной артериальной гипертонии –РЕзистентная Гипертония АрТериАльная (РЕГАТА):программа исследования
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Российское медицинское общество по артериальной гипертонии – Всероссийское научное общество кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр). М., 2008.
2. Cushman WC, Ford CE, Cutler JA et al. for the ALLHAT Collaboratyive Research Group. Success and predictors of blood pressure control in diverse North American Settings: the Antihypertensive and Lipid-Lowering and Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4: 393–404.
3. Garg JP, Elliott WJ, Folker A et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 2005; 18 (5 Pt. 1): 619–26.
4. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001; 14 (12): 1263–9.
5. Чазова И.Е., Фомин В.В. Резистентная артериальная гипертензия. Тер. арх. 2008; 6: 72–9.
6. Sloand JA, Balakroshnan SL, Fong MW, Bisognano JD. Evaluation and treatment of resistant hypertension. Cardiology J 2007; 14 (4): 329–39.
7. Calhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation and teratment: A scientific statement form the American Heart Association professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510–26.
8. Wojciechowski D, Papademetriou V, Faselis C, Fletcher R. Evaluation and treatment of resistant or difficult-to-control hypertension. J Clin Hypertens (Greenwich) 2008; 10 (11): 837–43
9. Ceral J, Solar M. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Blood Press 2009; 18 (1): 74–7.
10. Jameson K, Weber MA, Bakris GL et al. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417–28.
11. Poldermans D, Glazer R, Karagiannis G et al. Tolerability and blood pressure lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrichlorothiazide in adult patients with stage 2 hypertension. Clin Ther 2007; 29: 279–89.
12. Smith TR, Philipp T, Vaisse B et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly and black hypertensive patients: subgroup analysis of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) 2007; 9: 355–64.
13. Philipp T, Smith TR, Glazer R et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007; 29 (4): 563–80.
14. Fogari R, Zoppi A, Derosa G et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007; 21 (3): 220–4.
15. Trenkwalder P, Schaetzl R, Borbas E et al. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by ACE inhibitor/CCB combination. Blood Press 2008; 17 (4): 13–21.
16. Alleman Y, Fraile B, Lambert M et al. Efficacy of the combination of amlodipine and valsartan in patients uncontrolled with monotherapy: the Exforge in Failure after Single Therapy (Ex-FAST) Study. J Clin Hypertens (Greenwich) 2008; 10 (3): 185–94.
2. Cushman WC, Ford CE, Cutler JA et al. for the ALLHAT Collaboratyive Research Group. Success and predictors of blood pressure control in diverse North American Settings: the Antihypertensive and Lipid-Lowering and Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4: 393–404.
3. Garg JP, Elliott WJ, Folker A et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 2005; 18 (5 Pt. 1): 619–26.
4. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001; 14 (12): 1263–9.
5. Чазова И.Е., Фомин В.В. Резистентная артериальная гипертензия. Тер. арх. 2008; 6: 72–9.
6. Sloand JA, Balakroshnan SL, Fong MW, Bisognano JD. Evaluation and treatment of resistant hypertension. Cardiology J 2007; 14 (4): 329–39.
7. Calhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation and teratment: A scientific statement form the American Heart Association professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510–26.
8. Wojciechowski D, Papademetriou V, Faselis C, Fletcher R. Evaluation and treatment of resistant or difficult-to-control hypertension. J Clin Hypertens (Greenwich) 2008; 10 (11): 837–43
9. Ceral J, Solar M. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Blood Press 2009; 18 (1): 74–7.
10. Jameson K, Weber MA, Bakris GL et al. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417–28.
11. Poldermans D, Glazer R, Karagiannis G et al. Tolerability and blood pressure lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrichlorothiazide in adult patients with stage 2 hypertension. Clin Ther 2007; 29: 279–89.
12. Smith TR, Philipp T, Vaisse B et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly and black hypertensive patients: subgroup analysis of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) 2007; 9: 355–64.
13. Philipp T, Smith TR, Glazer R et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007; 29 (4): 563–80.
14. Fogari R, Zoppi A, Derosa G et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007; 21 (3): 220–4.
15. Trenkwalder P, Schaetzl R, Borbas E et al. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by ACE inhibitor/CCB combination. Blood Press 2008; 17 (4): 13–21.
16. Alleman Y, Fraile B, Lambert M et al. Efficacy of the combination of amlodipine and valsartan in patients uncontrolled with monotherapy: the Exforge in Failure after Single Therapy (Ex-FAST) Study. J Clin Hypertens (Greenwich) 2008; 10 (3): 185–94.
Авторы
И.Е.Чазова, В.В.Фомин, М.А.Разуваева,А.В.Вигдорчик
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.